JEF - Jefferies Financial Group Inc.
NYSE
->
Financial Services
->
Financial Conglomerates
New York,
United States
Type: Equity
JEF price evolution
JEF
| (in millions $) | 1 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $11939.02 | $8811.04 | $9940.96 | |
| Short term investments | ||||
| Net receivables | $5305.21 | $6114.37 | $5480.75 | $4716.3 |
| Inventory | ||||
| Total current assets | $17239 | $18053.39 | $14291.78 | $14657.26 |
| Long term investments | ||||
| Property, plant & equipment | $1229.03 | $1206.49 | $1103.49 | $1065.68 |
| Goodwill & intangible assets | $1822.81 | $1824.04 | $1847.86 | |
| Total noncurrent assets | ||||
| Total investments | $30838.63 | $32025.9 | $28937.37 | |
| Total assets | $63275.1 | $63000.53 | $60933 | $57905.16 |
| Current liabilities | ||||
| Accounts payable | $8319.52 | $8178.39 | $8149.94 | $7698.37 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $26190.91 | $26652.23 | $26527.34 | $24548.18 |
| Long term debt | $14661.33 | $14212.54 | $11347.03 | $11129.63 |
| Total noncurrent liabilities | ||||
| Total debt | $39436.11 | $36775.83 | $34835.08 | |
| Total liabilities | $53229.15 | $53047.94 | $51065.13 | $48102.62 |
| Shareholders' equity | ||||
| Retained earnings | $8124.13 | $8022.55 | $7937.91 | $7849.84 |
| Other shareholder equity | -$190.56 | -$410.73 | -$396.44 | -$395.55 |
| Total shareholder equity | $9875.06 | $9780.1 | $9709.83 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9940.96 | $10660.41 | $11770.24 | $9659.47 |
| Short term investments | ||||
| Net receivables | $4716.3 | $3586.99 | $7839.24 | $6608.77 |
| Inventory | ||||
| Total current assets | $14657.26 | $13290.1 | $18594.37 | $16268.24 |
| Long term investments | $14838.73 | |||
| Property, plant & equipment | $1065.68 | $906.86 | $911.23 | $897.2 |
| Goodwill & intangible assets | $1847.86 | $1736.11 | $1897.5 | $1913.47 |
| Total noncurrent assets | $36850.12 | |||
| Total investments | $28937.37 | $24639.8 | $29216.94 | $24907.91 |
| Total assets | $57905.16 | $51057.68 | $60404.11 | $53118.35 |
| Current liabilities | ||||
| Accounts payable | $7698.37 | $6207.58 | $13612.37 | $10388.07 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $24548.18 | $29817.81 | $32728.5 | $9080.98 |
| Long term debt | $11129.63 | $10937.93 | $13738.2 | $10162.79 |
| Total noncurrent liabilities | $34598.84 | |||
| Total debt | $34835.08 | $30382.85 | $34528.69 | $31323.81 |
| Total liabilities | $48102.62 | $40824.84 | $49674.07 | $43530.15 |
| Shareholders' equity | ||||
| Retained earnings | $7849.84 | $8418.35 | $7940.11 | $6531.84 |
| Other shareholder equity | -$395.55 | -$269 | -$372.14 | -$288.92 |
| Total shareholder equity | $9709.83 | $10232.85 | $10553.75 | $9403.89 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4700.42 | $5978.84 | $6010.87 | |
| Cost of revenue | $396.14 | $788.64 | $605.18 | |
| Gross Profit | $4304.28 | $5190.2 | $5405.69 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $3356.97 | $3333.62 | $4019.82 | |
| Total operating expenses | $3950.01 | $4134.63 | $4178.26 | |
| Operating income | $354.27 | $1055.56 | $1227.44 | |
| Income from continuing operations | ||||
| EBIT | $369.57 | $1059.3 | $1158.78 | |
| Income tax expense | $91.88 | $273.85 | $298.67 | |
| Interest expense | $84.87 | |||
| Net income | ||||
| Net income | $277.69 | $785.45 | $775.24 | |
| Income (for common shares) | $263.07 | $777.17 | $769.61 | |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $159.48 | $163.83 | $71.94 | |
| Operating activities | ||||
| Depreciation | $49.52 | $44.2 | $28.58 | |
| Business acquisitions & disposals | $83.45 | -$42.77 | $190 | |
| Stock-based compensation | $14.36 | $20.21 | $9.88 | |
| Total cash flows from operations | $32.68 | -$1302.9 | -$43.65 | |
| Investing activities | ||||
| Capital expenditures | -$48.62 | -$96.24 | $79.06 | |
| Investments | -$6.27 | -$25.22 | ||
| Total cash flows from investing | $316.84 | $34.83 | -$145.29 | $243.83 |
| Financing activities | ||||
| Dividends paid | -$221.39 | -$69.91 | -$69.91 | -$69.98 |
| Sale and purchase of stock | -$0.95 | -$43.03 | -$4.13 | |
| Net borrowings | $3246.53 | $430.95 | $116.02 | |
| Total cash flows from financing | $3630.44 | $3181.68 | $317.61 | $42.24 |
| Effect of exchange rate | $18.9 | $0.17 | -$1.68 | $55.13 |
| Change in cash and equivalents | $2034.07 | $3253.75 | -$1132.27 | $1082.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $277.69 | $785.45 | $1674.35 | $775.24 |
| Operating activities | ||||
| Depreciation | $113.47 | $189.34 | $151.17 | $142.39 |
| Business acquisitions & disposals | $80.19 | $244.97 | $2323.55 | $1735.63 |
| Stock-based compensation | $45.36 | $43.92 | $78.16 | $40.04 |
| Total cash flows from operations | -$1933.63 | $1804.85 | $1573.02 | $2075.95 |
| Investing activities | ||||
| Capital expenditures | -$1.16 | -$224.3 | -$165.6 | -$171.84 |
| Investments | -$91.23 | -$89.85 | -$2557.36 | -$1749.98 |
| Total cash flows from investing | -$12.2 | -$60.54 | -$400.59 | -$186.19 |
| Financing activities | ||||
| Dividends paid | -$278.6 | -$280.1 | -$222.8 | -$160.94 |
| Sale and purchase of stock | -$169.4 | -$859.59 | -$269.4 | -$816.87 |
| Net borrowings | $1470.56 | -$1768.53 | $1496.63 | $235.33 |
| Total cash flows from financing | $1060.12 | -$2843.22 | $994.29 | -$723.52 |
| Effect of exchange rate | $54.91 | -$22.14 | -$3.39 | $18.31 |
| Change in cash and equivalents | -$45.69 | -$1121.06 | $2163.33 | $1184.54 |
News
|
Jefferies Hires Two Senior Traders From CLSA in Asia Push
Bloomberg
21 Feb 2025
|
|
HBM Considers $1.7 Billion Sale of Swixx Biopharma
Bloomberg · via Yahoo Finance
21 Feb 2025
|
|
European IPOs Show Positive Signs After Bumpy Start to 2025
Bloomberg · via Yahoo Finance
20 Feb 2025
|
|
Jefferies Warns of Slowing Equity Inflows From Local Investors
Bloomberg
13 Feb 2025
|
|
After Banker Dies, Jefferies Vows Support and Slams Online Venom
Bloomberg
1 Feb 2025
|
|
Research Analysts’ Recent Ratings Updates for AppLovin (APP)
ETF DAILY NEWS
31 Jan 2025
|
|
Rare China Support Shows Vanke May Be Too Big to Fail
Bloomberg · via Yahoo Finance
28 Jan 2025
|
|
Jefferies 28-Year-Old Technology Banker Carter McIntosh Dies
Bloomberg
28 Jan 2025
|
|
Jefferies Financial Group (NYSE:JEF) Is Paying Out A Larger Dividend Than Last...
Simply Wall St. · via Yahoo Finance
16 Jan 2025
|
|
Steven Romick's Strategic Moves: A Closer Look at Eurofins Scientific SE
GuruFocus.com · via Yahoo Finance
15 Jan 2025
|
Fundamentals
| Market cap | $8.87B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 205.50M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 4.95 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.66 |
| Quick ratio | N/A |